ProShares UltraShort Nasdaq BiotechnologyProShares UltraShort Nasdaq BiotechnologyProShares UltraShort Nasdaq Biotechnology

ProShares UltraShort Nasdaq Biotechnology

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪3.61 M‬USD
Fund flows (1Y)
‪−681.31 K‬USD
Dividend yield (indicated)
2.99%
Discount/Premium to NAV
0.10%
Shares outstanding
‪191.10 K‬
Expense ratio
0.95%

About ProShares UltraShort Nasdaq Biotechnology


Issuer
ProShare Advisors LLC
Brand
ProShares
Home page
Inception date
Apr 7, 2010
Structure
Open-Ended Fund
Index tracked
NASDAQ / Biotechnology
Replication method
Synthetic
Management style
Passive
Dividend treatment
Distributes
Distribution tax treatment
Ordinary income
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
ProShare Advisors LLC
Distributor
SEI Investments Distribution Co.
BIS is one available fund that provides exposure to the biotech space aiming for daily geared inverse (-2x) exposure to the NASDAQ Biotechnology Index (comprised of companies that are classified as either biotechnology or pharmaceutical). The fund expects to typically hold derivatives and money market instruments. Note: BIS is a tactical tool, it is not a buy-and-hold investment and should not be expected to provide index leverage returns greater than a one-day period.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharma, biotech & life sciences
Strategy
Exchange-specific
Geography
U.S.
Weighting scheme
Market cap
Selection criteria
NASDAQ - listed

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of April 3, 2025
Exposure type
Bonds, Cash & Other
Cash
Bonds, Cash & Other100.00%
Cash97.34%
Government2.66%
Stock breakdown by region
100%
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows